Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

World of Change Coming For Device Manufacturers: Developments In FDA And International Inspections

Executive Summary

Device companies have an opportunity to leverage several major reforms and initiatives that are getting off the ground related to global facility inspections. But firms must constructively engage with the new programs to reap benefits, say Akin Gump attorneys and former top US FDA officials Nathan Brown and Howard Sklamberg in this guest column.

Advertisement

Related Content

US FDA Inspections & FDARA: Will New Law Light The Way For Investigators? Maybe, Experts Say
MDUFA IV (And More) Is Law: Trump Signs A Health-Care Bill
'Program Alignment' Falls Into Place: Everything You Need To Know About US FDA's New Inspectional Approach
More Manufacturers Sign Up For Single Audits As MDSAP Becomes Operational

Topics

Advertisement
UsernamePublicRestriction

Register

MT105368

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel